(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention ...

Modern medication regimens have transformed HIV from a deadly disease into a chronic disease, with some patients now ...

Every week, 4000 young women contract HIV. Discover hidden barriers to prevention and innovative solutions that can change ...

The government provides HIV medicines free of charge. Yet in one Indigenous territory, cases and deaths are increasing at an ...

The Supreme Court said Friday it will review the constitutionality of the Affordable Care Act’s no-cost coverage mandates for ...

But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...

Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was ...

Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells ...

Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Here are some of the findings from UNAIDS' new report on HIV and human rights, and what they could mean for the fight against ...

Memphis ranked second in the country for new HIV infections among metropolitan areas in the United States, according to the ...